Infrared / IR
Predicting the Release of APIs by Near-Infrared Spectroscopy
Oct 20 2014
Sustained-release formulations that gradually release active pharmaceutical ingredients (APIs) have numerous therapeutic benefits, but they also involve time-consuming quality control. Near-infrared spectroscopy (NIRS) offers a fast and simple alternative to tedious dissolution testing: by using NIRS and appropriate calibration models, the release of APIs from sustained-release tablets can be predicted accurately within a matter of minutes. More details are available from a recently published paper.
Drug release is still frequently assessed by dissolution tests, a procedure, in which the tablet is placed in a solvent with similar properties to gastric acid. The free active ingredient is then determined at regular intervals, which can take up to 24 hours, depending on the desired release period.
NIRS offers a viable alternative to dissolution testing. By using NIRS together with an appropriate calibration model, it is possible to predict the dissolution behaviour of tablets accurately in a matter of minutes. Moreover, NIRS, unlike dissolution testing, is non-destructive, which allows larger sample quantities to be analysed.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark